Normal view MARC view ISBD view

PCSK9 Inhibition for Therapeutic Decision-Making: Assessing the Value.

PCSK9 Inhibition for Therapeutic Decision-Making: Assessing the Value. - 2020

Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007

English

ISSN: 0735-1097

Standard No.: 10.1016/j.jacc.2020.03.037 [doi] S0735-1097(20)34648-9 [pii]

Subjects--Topical Terms:
*Acute Coronary Syndrome
*Proprotein Convertase 9
Antibodies, Monoclonal, Humanized
Cost-Benefit Analysis
Humans

Subjects--Geographic Terms:
MedStar Heart & Vascular Institute

Index Terms--Function:
Editorial

Print
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)